REGENXBIO Inc. - RGNX
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$598.5M
QoQ value delta ($000)
+$197.6M
(+49.29%)
Implied price effect (QoQ)
+49.36%
Shares
Total shares
41,521,952
QoQ shares delta
-20,671
(-0.05%)
Total shares held by funds (by quarter)
Market chart (RGNX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q1 2026 data: only 15 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| BlackRock, Inc. | 82,898 | 5,756,811 | 0.0% |
| Redmile Group, LLC | 62,910 | 4,368,804 | 4.63% |
| JPMORGAN CHASE & CO | 51,170 | 3,553,502 | 0.0% |
| VANGUARD GROUP INC | 48,587 | 3,374,140 | 0.0% |
| STATE STREET CORP | 32,928 | 2,286,736 | 0.0% |
| MORGAN STANLEY | 29,012 | 2,014,788 | 0.0% |
| GOLDMAN SACHS GROUP INC | 25,710 | 1,785,437 | 0.0% |
| AQR CAPITAL MANAGEMENT LLC | 19,612 | 1,361,962 | 0.01% |
| Integral Health Asset Management, LLC | 17,280 | 1,200,000 | 0.86% |
| Assenagon Asset Management S.A. | 16,709 | 1,160,380 | 0.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 16,495 | 1,145,206 | 0.0% |
| 22NW, LP | 13,300 | 923,679 | 5.6% |
| DIMENSIONAL FUND ADVISORS LP | 13,014 | 903,851 | 0.0% |
| Nuveen, LLC | 9,482 | 658,510 | 0.0% |
| Pale Fire Capital SE | 7,193 | 499,526 | 0.48% |
| Qube Research & Technologies Ltd | 6,374 | 442,690 | 0.01% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 5,637 | 391,461 | 0.0% |
| ACADIAN ASSET MANAGEMENT LLC | 5,404 | 375,399 | 0.01% |
| NORTHERN TRUST CORP | 5,381 | 373,689 | 0.0% |
| STIFEL FINANCIAL CORP | 4,824 | 335,046 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 4,796 | 333,086 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 4,328 | 300,609 | 0.0% |
| HRT FINANCIAL LP | 4,318 | 299,915 | 0.01% |
| Voss Capital, LP | 4,248 | 295,000 | 0.2% |
| GSK plc | 3,908 | 271,456 | 0.49% |